Patient Leaflet Updated 28-May-2026 | Rosemont Pharmaceuticals Limited
Apixaban 1mg/1ml Oral Suspension
Apixaban 1mg/ml Oral Suspension
1. What Apixaban is and what it is used for
2. What you need to know before you take Apixaban
3. How to take Apixaban
4. Possible side effects
5. How to store Apixaban
6. Contents of the pack and other information
The full name of your medicine is Apixaban 1mg/ml Oral Suspension. In this leaflet the shorter name Apixaban is used.
Apixaban contains the active substance apixaban and belongs to a group of medicines called anticoagulants. This medicine helps to prevent blood clots from forming by blocking Factor Xa, which is an important component of blood clotting.
Apixaban is used in adults:
Talk to your doctor, pharmacist or nurse before you take this medicine if you have any of the following:
Take special care with Apixaban
If you need to have surgery or a procedure which may cause bleeding, your doctor might ask you to temporarily stop taking this medicine for a short while. If you are not sure whether a procedure may cause bleeding ask your doctor.
This medicine is not recommended in children and adolescents under 18 years of age.
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.
Some medicines may increase the effects of Apixaban and some may decrease its effects. Your doctor will decide, if you should be treated with Apixaban when taking these medicines and how closely you should be monitored.
The following medicines may increase the effects of Apixaban and increase the chance for unwanted bleeding:
The following medicines may reduce the ability of Apixaban to help prevent blood clots from forming:
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor, pharmacist or nurse for advice before taking this medicine.
The effects of Apixaban on pregnancy and the unborn child are not known. You should not take this medicine if you are pregnant. Contact your doctor immediately if you become pregnant while taking this medicine.
It is not known if Apixaban passes into human breast milk. Ask your doctor, pharmacist or nurse for advice before taking this medicine while breast-feeding. They will advise you whether to stop breast-feeding or to stop/not start taking this medicine.
Apixaban has not been shown to impair your ability to drive or use machines.
Apixaban contains sorbitol and sodium benzoate:
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor, pharmacist or nurse if you are not sure.
Apixaban can be taken with or without food. Take Apixaban Oral Suspension with a glass of water.
Try to take the oral suspension at the same times every day to have the best treatment effect.
If necessary, your doctor may also give you Apixaban, through a nasogastric tube.
Take Apixaban as recommended for the following:
To prevent blood clots from forming after hip or knee replacement operations.
The recommended dose is 2.5 mg (2.5 ml) twice a day. For example, one in the morning and one in the evening.
You should take the first dose 12 to 24 hours after your operation.
If you have had a major hip operation you will usually take the oral suspension for 32 to 38 days.
If you have had a major knee operation you will usually take the oral suspension for 10 to 14 days.
To prevent a blood clot from forming in the heart in patients with an irregular heart beat and at least one additional risk factor.
The recommended dose of Apixaban Oral Suspension is 5 mg (5 ml) twice a day.
The recommended dose of Apixaban Oral Suspension is 2.5 mg (2.5 ml) twice a day if:
The recommended dose is Apixaban Oral Suspension twice a day, for example, one in the morning and one in the evening.
Your doctor will decide how long you must continue treatment for.
To treat blood clots in the veins of your legs and blood clots in the blood vessels of your lungs
The recommended dose of Apixaban Oral Suspension is 5 mg (5 ml) twice a day for the first 7 days, for example, two in the morning and two in the evening.
After 7 days the recommended dose of Apixaban Oral Suspension is 5 mg (5 ml) twice a day, for example, one in the morning and one in the evening.
For preventing blood clots from re-occurring following completion of 6 months of treatment
The recommended dose of Apixaban Oral Suspension is 2.5 mg (2.5 ml) twice a day for example, one in the morning and one in the evening.
Your doctor will decide how long you must continue treatment for.
Your doctor might change your anticoagulant treatment as follows:
Stop taking Apixaban. Start treatment with the anticoagulant medicines (for example heparin) at the time you would have taken the next dose of oral suspension.
Stop taking the anticoagulant medicines. Start treatment with Apixaban at the time you would have had the next dose of anticoagulant medicine, then continue as normal.
Stop taking the medicine containing a vitamin K antagonist. Your doctor needs to do blood-measurements and instruct you when to start taking Apixaban.
If your doctor tells you that you have to start taking the medicine containing a vitamin K antagonist, continue to take Apixaban for at least 2 days after your first dose of the medicine containing a vitamin K antagonist. Your doctor needs to do blood-measurements and instruct you when to stop taking Apixaban.
If your abnormal heartbeat needs to be restored to normal by a procedure called cardioversion, take this medicine at the times your doctor tells you, to prevent blood clots in blood vessels in your brain and other blood vessels in your body.
The oral suspension must be shaken well before use.
Tell your doctor immediately if you have taken more than the prescribed dose of Apixaban. Take the medicine pack with you, even if there are no oral suspension left.
If you take more Apixaban than recommended, you may have an increased risk of bleeding. If bleeding occurs, surgery, blood transfusions, or other treatments that may reverse anti-factor Xa activity may be required.
If you are not sure what to do or have missed more than one dose, ask your doctor, pharmacist or nurse.
Do not stop taking this medicine without talking to your doctor first, because the risk of developing a blood clot could be higher if you stop treatment too early.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them. Apixaban can be given for three different medical conditions. The known side effects and how frequently they occur for each of these medical conditions may differ and are listed separately below. For these conditions, the most common general side effect of this medicine is bleeding which may be potentially life threatening and require immediate medical attention.
The following side effects are known if you take Apixaban to prevent blood clots from forming after hip or knee replacement operations.
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Not known (frequency cannot be estimated from the available data)
The following side effects are known if you take Apixaban to prevent a blood clot from forming in the heart in patients with an irregular heart beat and at least one additional risk factor.
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people)
Not known (frequency cannot be estimated from the available data)
The following side effects are known if you take Apixaban to treat or prevent re-occurrence of blood clots in the veins of your legs and blood clots in the blood vessels of your lungs.
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Not known (frequency cannot be estimated from the available data)
If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Apixaban is an off-white oral suspension.
Apixaban oral suspension comes in a white opaque HDPE bottle with a white child resistant tamper evident expanded polypropylene (TE/PP) closure, containing 150 ml of liquid product.
The package contains a 5ml oral syringe with 1.25ml graduations together with a low-density polyethylene bottle adaptor.
Patient Alert Card: handling information
Inside the Apixaban pack together with the package leaflet you will find a Patient Alert Card or your doctor might give you a similar card.
This Patient Alert Card includes information that will be helpful to you and alert other doctors that you are taking Apixaban. You should keep this card with you at all times.
1. Take the card.
2. Complete the following sections or ask your doctor to do it:
3. Fold the card and keep it with you at all times.
This leaflet was last revised in 05/2026
If you would like the leaflet in an alternative format information (braille or large print), for blind and partially sighted patients, please contact marketing authorisation holder listed above.
A6AD1RBJ2
V2
PLEF0456-1-439
CUG/PL/009
Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, Yorkshire, LS11 9XE
+44 (0)113 245 3567
+44 (0)800 919 312
+44 (0)795 762 3515
+44 (0)113 244 1400
http://www.rosemontpharma.com